ICON Public Limited Company ICON Public Limited Company

ICON Public Limited Company

ICLR

Classificação em ações #1606
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Preço da ação
$174.32
Última sincronização: 2026-10-20
Valor de mercado
$13.45B
Variação (1 dia)
3.68%
Variação (1 ano)
-9.80%
País
IE
Negociar ICON Public Limited Company (ICLR)

Categoria

Healthcare
Receita da ICON Public Limited Company (ICLR)
Receita em Jun 2026 TTM: $8.25B
De acordo com os últimos relatórios financeiros da ICON Public Limited Company, a receita atual da empresa (TTM) é $8.25B. Em 2023, a empresa obteve uma receita de $8.12B um aumento em relação a a receita do ano 2022, que foi de $7.74B. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da ICON Public Limited Company de 2001 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $8.25B -0.35%
2024 $8.28B 1.99%
2023 $8.12B 4.89%
2022 $7.74B 41.24%
2021 $5.48B 95.93%
2020 $2.80B -0.30%
2019 $2.81B 8.09%
2018 $2.60B 47.62%
2017 $1.76B 5.52%
2016 $1.67B 5.81%
2015 $1.57B 4.77%
2014 $1.50B 12.52%
2013 $1.34B 19.83%
2012 $1.12B 17.90%
2011 $945.73M 5.08%
2010 $900.04M 1.40%
2009 $887.61M 2.58%
2008 $865.25M 37.18%
2007 $630.72M 38.44%
2006 $455.60M 31.60%
2005 $346.20M 16.60%
2004 $296.92M 31.54%
2003 $225.73M 44.18%
2002 $156.56M 34.77%
2001 $116.16M 0.00%
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
$46.34B 461.46%
US
$25.11B 204.22%
US
$2.71B -67.20%
US
- -
CN
$7.37B -10.67%
US